Verastem Stock Net Income
| 2VSA Stock | 4.84 0.36 6.92% |
As of the 15th of February 2026, Verastem, has the Variance of 22.34, coefficient of variation of (1,269), and Risk Adjusted Performance of (0.06). Verastem, technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Verastem, treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if Verastem, is priced more or less accurately, providing market reflects its prevalent price of 4.84 per share.
Verastem, Total Revenue |
|
Gross Profit | Market Capitalization | Revenue | Earnings Share (3.64) | Revenue Per Share |
| Last Reported | Projected for Next Year | ||
| Net Loss | -117.6 M | -111.7 M | |
| Net Loss | -117.6 M | -123.5 M | |
| Net Loss | (3.29) | (3.46) | |
| Net Income Per E B T | 1.15 | 1.10 |
Verastem, | Net Income |
The Net Income trend for Verastem offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Verastem, is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Verastem,'s Net Income Growth Pattern
Below is the plot of the Net Income of Verastem over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Verastem, financial statement analysis. It represents the amount of money remaining after all of Verastem operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Verastem,'s Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Verastem,'s overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (130.64 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Verastem, Net Income Regression Statistics
| Arithmetic Mean | (70,451,584) | |
| Coefficient Of Variation | (55.49) | |
| Mean Deviation | 29,448,736 | |
| Median | (67,802,000) | |
| Standard Deviation | 39,091,737 | |
| Sample Variance | 1528.2T | |
| Range | 135.5M | |
| R-Value | (0.82) | |
| Mean Square Error | 525.6T | |
| R-Squared | 0.68 | |
| Significance | 0.000049 | |
| Slope | (6,372,157) | |
| Total Sum of Squares | 24450.6T |
Verastem, Net Income History
Verastem, Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Verastem, is extremely important. It helps to project a fair market value of Verastem, Stock properly, considering its historical fundamentals such as Net Income. Since Verastem,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Verastem,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Verastem,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Verastem, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verastem,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verastem,.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Verastem, on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Verastem or generate 0.0% return on investment in Verastem, over 90 days. Verastem, is related to or competes with Novo Nordisk, Vertex Pharmaceuticals, UCB SA, UCB SA, Mercedes Benz, CSL, and Argen X. Verastem, is entity of Germany. It is traded as Stock on F exchange. More
Verastem, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verastem,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verastem upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 28.15 | |||
| Value At Risk | (6.92) | |||
| Potential Upside | 4.76 |
Verastem, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verastem,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verastem,'s standard deviation. In reality, there are many statistical measures that can use Verastem, historical prices to predict the future Verastem,'s volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | 0.3808 |
Verastem, February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.3908 | |||
| Mean Deviation | 3.48 | |||
| Coefficient Of Variation | (1,269) | |||
| Standard Deviation | 4.73 | |||
| Variance | 22.34 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | 0.3808 | |||
| Maximum Drawdown | 28.15 | |||
| Value At Risk | (6.92) | |||
| Potential Upside | 4.76 | |||
| Skewness | 0.9995 | |||
| Kurtosis | 3.99 |
Verastem, Backtested Returns
Verastem, owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0723, which indicates the firm had a -0.0723 % return per unit of risk over the last 3 months. Verastem exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verastem,'s Coefficient Of Variation of (1,269), variance of 22.34, and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide. The entity has a beta of -1.0, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Verastem, are expected to decrease slowly. On the other hand, during market turmoil, Verastem, is expected to outperform it slightly. At this point, Verastem, has a negative expected return of -0.34%. Please make sure to validate Verastem,'s treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if Verastem, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.30 |
Below average predictability
Verastem has below average predictability. Overlapping area represents the amount of predictability between Verastem, time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verastem, price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current Verastem, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.18 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Verastem, Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Verastem reported net income of (130.64 Million). This is 138.28% lower than that of the Healthcare sector and 286.5% lower than that of the Biotechnology industry. The net income for all Germany stocks is 122.88% higher than that of the company.
Verastem, Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verastem,'s direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Verastem, could also be used in its relative valuation, which is a method of valuing Verastem, by comparing valuation metrics of similar companies.Verastem is currently under evaluation in net income category among its peers.
Verastem, Fundamentals
| Return On Equity | -28.89 | ||||
| Return On Asset | -0.66 | ||||
| Operating Margin | (3.62) % | ||||
| Current Valuation | 372.46 M | ||||
| Shares Outstanding | 75.32 M | ||||
| Shares Owned By Insiders | 0.59 % | ||||
| Shares Owned By Institutions | 83.48 % | ||||
| Revenue | 10 M | ||||
| Gross Profit | 11.39 M | ||||
| EBITDA | (125.86 M) | ||||
| Net Income | (130.64 M) | ||||
| Total Debt | 42.25 M | ||||
| Book Value Per Share | (0.20) X | ||||
| Cash Flow From Operations | (104.77 M) | ||||
| Earnings Per Share | (3.64) X | ||||
| Number Of Employees | 78 | ||||
| Beta | 0.44 | ||||
| Market Capitalization | 560.69 M | ||||
| Total Asset | 101.54 M | ||||
| Retained Earnings | (955.53 M) | ||||
| Working Capital | 63.99 M | ||||
| Net Asset | 101.54 M |
About Verastem, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verastem, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.